Clinical Trial Update: The Safety and Dosimetry Study of 177Lu-LNC1004 Injection [Phase 1]

View source ↗

Summary

This clinical trial update reports safety and dosimetry findings from a Phase 1 study of the radiopharmaceutical 177Lu-LNC1004 Injection in adults with solid tu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• 177Lu-LNC1004 Injection (177Lu-LNC1004)

Snippet

Sponsor: Yantai LNC Biotechnology Singapore PTE. LTD. | Conditions: Solid Tumor, Unspecified, Adult | Phase 1 | Status: COMPLETED